Evidence map›Paper›PMID 29561852›Full record

ArticlePloS one2018

Proteomic endorsed transcriptomic profiles of venom glands from Tityus obscurus and T. serrulatus scorpions.

Ursula Castro de Oliveira, Milton Yutaka Nishiyama, Maria Beatriz Viana Dos Santos, Andria de Paula Santos-da-Silva, Hipócrates de Menezes Chalkidis, Andreia Souza-Imberg, Denise Maria Candido, Norma Yamanouye, Valquíria Abrão Coronado Dorce, Inácio de Loiola Meirelles Junqueira-de-Azevedo

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Refining the NaFEBS letters · 2025
    Article
  9. Article
  10. The First KToxins · 2025
    Article
  11. Scorpionism in Pará, Brazil: Clinical assessment of neuromuscular manifestations.Revista da Sociedade Brasileira de Medicina Tropical · 2025
    Observational
  12. Article
  13. Article
  14. Review
  15. Venomics of ScorpionToxins · 2024
    Article
  16. Review
  17. Understanding the complexity ofThe journal of venomous animals and toxins including tropical diseases · 2024
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Ursula Castro de OliveiraLaboratório Especial de Toxinologia Aplicada, CeTICS, Instituto Butantan, São Paulo, São Paulo, Brazil.ORCID 0000-0002-4811-757X
Milton Yutaka NishiyamaLaboratório Especial de Toxinologia Aplicada, CeTICS, Instituto Butantan, São Paulo, São Paulo, Brazil.
Maria Beatriz Viana Dos SantosLaboratório de Farmacologia, Instituto Butantan, São Paulo, São Paulo, Brazil.
Andria de Paula Santos-da-SilvaLaboratório de Farmacologia, Instituto Butantan, São Paulo, São Paulo, Brazil.
Hipócrates de Menezes ChalkidisFaculdades Integradas do Tapajós, /Faculdade da Amazônia, Santarém, Pará, Brazil.
Andreia Souza-ImbergLaboratório de Farmacologia, Instituto Butantan, São Paulo, São Paulo, Brazil.
Denise Maria CandidoLaboratório de Artrópodes, Instituto Butantan, São Paulo, São Paulo, Brazil.
Norma YamanouyeLaboratório de Farmacologia, Instituto Butantan, São Paulo, São Paulo, Brazil.
Valquíria Abrão Coronado DorceLaboratório de Farmacologia, Instituto Butantan, São Paulo, São Paulo, Brazil.
Inácio de Loiola Meirelles Junqueira-de-AzevedoLaboratório Especial de Toxinologia Aplicada, CeTICS, Instituto Butantan, São Paulo, São Paulo, Brazil.
Instituto Butantan · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundExcept for the northern region, where the Amazonian black scorpion, T. obscurus, represents the predominant and most medically relevant scorpion species, Tityus serrulatus, the Brazilian yellow scorpion, is widely distributed throughout Brazil, causing most envenoming and fatalities due to scorpion sting. In order to evaluate and compare the diversity of venom components of Tityus obscurus and T. serrulatus, we performed a transcriptomic investigation of the telsons (venom glands) corroborated by a shotgun proteomic analysis of the venom from the two species.

resultsThe putative venom components represented 11.4% and 16.7% of the total gene expression for T. obscurus and T. serrulatus, respectively. Transcriptome and proteome data revealed high abundance of metalloproteinases sequences followed by sodium and potassium channel toxins, making the toxin core of the venom. The phylogenetic analysis of metalloproteinases from T. obscurus and T. serrulatus suggested an intraspecific gene expansion, as we previously observed for T. bahiensis, indicating that this enzyme may be under evolutionary pressure for diversification. We also identified several putative venom components such as anionic peptides, antimicrobial peptides, bradykinin-potentiating peptide, cysteine rich protein, serine proteinases, cathepsins, angiotensin-converting enzyme, endothelin-converting enzyme and chymotrypsin like protein, proteinases inhibitors, phospholipases and hyaluronidases.

conclusionThe present work shows that the venom composition of these two allopatric species of Tityus are considerably similar in terms of the major classes of proteins produced and secreted, although their individual toxin sequences are considerably divergent. These differences at amino acid level may reflect in different epitopes for the same protein classes in each species, explaining the basis for the poor recognition of T. obscurus venom by the antiserum raised against other species.

Indexed as

Gene Expression RegulationTranscriptomeAmino Acid SequenceAnimalsPhylogenyProteomeProteomicsScorpionsScorpion VenomsSequence HomologySpecies SpecificityProteomeScorpion Venoms

Identifiers

PMID29561852
PMCPMC5862453
OpenAlexW2794407781

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.